Antonia Lopez-girona

13 Patents

• US125105332025

  Methods for Treating Multiple Myeloma and the Use of Companion Biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile

  Celgene Corporation

  0 cites
• US124743422025

  Methods for Treating Cancer and the Use of Biomarkers as a Predictor of Clinical Sensitivity to Therapies

  Celgene Corporation

  0 cites
• US123969952025

  Substituted 4-aminoisoindoline-1,3-dione Compounds and Second Active Agents for Combined Use

  Celgene Corporation

  0 cites
• US121788222024

  Methods of Treating Hematological Malignancies Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dion

  Celgene Corporation

  0 cites
• US121039232024

  Methods of Treating Non-hodgkin Lymphoma Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione

  Celgene Corporation

  0 cites
• US120297382024

  Antiproliferative Compounds and Methods of Use Thereof

  Celgene Corporation

  0 cites
• US119458042024

  Substituted 4-aminoisoindoline-1,3-dione Compounds, Compositions Thereof, and Methods of Treatment Therewith

  Celgene Corporation

  0 cites
• US117332332023

  Compositions and Methods for Inducing Conformational Changes in Cereblon and Other E3 Ubiquitin Ligases

  CELGENE CORPORATION

  0 cites
• US117260802023

  Methods for Treating Multiple Myeloma and the Use of Companion Biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile

  Celgene Corporation

  0 cites
• US116665792023

  Methods of Treating Hematological Malignancies Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione

  Celgene Corporation

  0 cites
• US116281722023

  Methods of Treating Chronic Lymphocytic Leukemia Using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione

  Celgene Corporation

  0 cites
• US115901172023

  Treatment of a Hematologic Malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide

  Celgene Corporation

  0 cites
• US115835362023

  Substituted 4-aminoisoindoline-1,3-dione Compounds and Second Active Agents for Combined Use

  Celgene Corporation

  0 cites